(D-Arg0,Hyp3,beta-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin is a modified bradykinin peptide with substitutions that influence receptor interaction and metabolic stability. The peptide is used to study bradykinin's effects on vasodilation and pain signaling. Researchers use it to explore the role of bradykinin in inflammation, particularly in chronic pain conditions and vascular diseases.
CAT No: B09034
CAS No:103412-36-8
Synonyms/Alias:B4307, Hoe k86-4321, Ahtp-BK
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.